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Abstract 
 
Warfarin is a vitamin K antagonist that is the most commonly prescribed anticoagulant and 
continued use is anticipated even with the new anticoagulants.  It is well known that warfarin has 
a narrow therapeutic range, potential life-threatening side effects and is known for multiple drug-
drug, drug-disease, and drug-food interactions. Despite these known interactions, there is very 
little consistency regarding the patient education, which is integral to any medication, especially 
in regards to warfarin which has such life-threatening side effects.  While many interactions are 
unavoidable, drug-food interactions can be controlled by the patient if they have received 
education.  Research has shown that by improving diet education regarding vitamin K content of 
foods, patients can have more stable INR values (Dennis, Ripley, Planas and Beach, 2008).  With 
adequate education, a patient is capable of maintaining a consistent daily vitamin K intake which 
will aid in his/her ability to maintain a therapeutic INR.  A review of the nursing literature from 
the last ten years has revealed an extreme deficit of information regarding specific vitamin K 
content of food items.  Since nurses are frequently in the position to offer formal and informal 
patient education, it is important that they possess essential knowledge about high-risk 
medications.  This enables nurses to educate their patients accurately about these medications. 
There is some highly detailed patient information available about food items and vitamin K 
content, but they are long, cumbersome lists.  In response, a clear, concise patient tool has been 
created that sorts foods into categories of low, moderate, high, and extremely high and also 
groups some food items for simplicity to keep the tool to a single page. It is the aim of this tool 
to improve patient and nursing education as well as increase patient diet choices regarding 
vitamin K content of foods which should lead to improvement in maintenance of therapeutic 
INR.   
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Introduction 
 
Warfarin is a well-known blood thinner commonly prescribed to prevent blood clots.  
Even though it is being used by about 2 million people (Agency for HealthCare Research and 
Quality, 2010), it is not a popular drug with patients because of the many lifestyle changes that 
are required while on the drug.  Specifically, warfarin is an oral vitamin K antagonist used 
primarily in approximately four million U.S. patients for the prevention of primary and 
secondary venous thromboembolisms (Ansell, Hirsh, Poller, Bussey, Jacobson, & Hylek, 2004; 
Nutescu, Wittkowsky, Burnett, Merli, Ansell, & Garcia, 2013).  It is the most commonly used 
vitamin K antagonist (VKA) worldwide, but its use with inpatient and outpatient settings can be 
problematic.  It has a very narrow therapeutic range, there is considerable variability in patient 
dosage, it has numerous drug-drug, drug-disease, and drug-food interactions, and physicians 
have numerous problems maintaining therapeutic levels in patients due to non-adherence and 
miscommunication (Ansell et al., 2004).     
While three new oral anticoagulants have been approved by the U.S. Food and Drug 
Administration, dabigatran (Pradaxa®) in 2010, rivaroxaban (Xarelto®) in 2011, and apixaban 
(Eliquis®) in 2012, there are some drawbacks to using them.  While studies have shown that 
even though these new medications have fewer drug and food interactions, a lower bleeding risk, 
and no laboratory monitoring, they have significant disadvantages.  There is no antidote or 
testing for effectiveness and toxicity which can be problematic especially if a patient needs 
emergency surgery.  This inability to determine if the dosage is therapeutic increases the risk of 
hemorrhaging. The long-term safety and effectiveness of these new medications is also missing 
along with limited usage by the FDA (Wigle, Bloomfield, Tubb, & Doherty, 2013; Wanat, 
2013.) 
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In addition to these limited uses, another disadvantage to consider is their short half-life.  
If a dosage is missed or held, this will increase the patient’s risk of a thromboembolic event 
compared to warfarin (Wanat, 2013).  Considering these short-comings and the cost-
effectiveness of warfarin at this time, it is assumed that warfarin will continue to remain the 
more commonly used oral anticoagulant world-wide for a variety of reasons (Cook-Campbell & 
Sefton, 2010).  Warfarin is the only oral anticoagulant currently recommended for valvular heart 
disease and coronary heart disease (Wigle et al., 2013).  Studies have also shown that in 79% of 
older patients with a chronic condition that maintain therapeutic INR levels on warfarin, they 
have a 79% reduced stroke risk without increasing their risk of complications from 
hemorrhaging (Venkatachalam, D'Attilio, Lewis, & Acevedo, 2007).   
 In a review of anticoagulation education and patient understanding, Moreland, Kravitz, 
Paterniti, Li, Lin, and White (2013) discuss how the Joint Commission’s National Patient Safety 
Goal and the Joint Commission Venous Thromboembolism (VTE) National Hospital Inpatient 
Quality Measure now require that providers educate patients and families who are prescribed any 
anticoagulant before they are discharged.  These two Joint Commission statements require that 
patient education include information on “follow-up monitoring, compliance, dietary restrictions, 
and the potential for adverse drug reactions and interactions” (Moreland et al., 2013.)  Even 
though patient education is now mandated and some studies have shown that pharmacist led 
education appears to have a more effective impact on patients over physician led (Moreland et 
al., 2013), warfarin continues to be implicated in multiple adverse drug events.  Current data 
indicate that VKA’s are associated with “approximately 7% of all medication errors” in 
hospitalized patients (Nutescu et al., 2013). Other studies (Davis, Billet, Cohen, & Arnsten, 
2005) have shown that patients are in therapeutic range only about one-third of the time.  In an 
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evaluation of the effectiveness of patient education, “the questions most often missed related to 
medication dosing or dietary interactions (Moreland et al., 2013).   
This is emphasized in a study of oral anticoagulation patient education done by Winans, 
Rudd, and Triller (2010). They assessed patient knowledge of warfarin using the Oral 
Anticoagulation Knowledge Test (OAK) developed by Zeolla, Brodeur, Dominelli, Haines, & 
Allie (2006).  They split their patients up into two groups 1) the “usual care” group which 
consisted of any new warfarin patient who had been educated in the usual way, typically a nurse 
with no standardized protocol and 2) the “intervention” group which consisted of new warfarin 
patients that were educated by a pharmacist in a more structured and standardized protocol that 
included “brand/generic name; indication; dosing and administration; missed doses; drug and 
dietary interactions; therapeutic, subtherapeutic, and supratherapeutic ; international normalized 
ratios (INR); monitoring; reversal of warfarin effects; adverse events; and emergency care.” 
Their results indicate that the “usual” group had a mean OAK score of 55% and their 
“structured” group had an average score of 74%, which surpassed their predetermined goal of 
72% based on patients taking the OAK test who were long-time warfarin users.  However, when 
the OAK test is examined in detail, out of twenty questions, only three are diet specific. (Zoella 
et al., 2006).   
 Another recent study by Dennis, Ripley, Planas and Beach (2008) specifically examines 
the role of vitamin K in oral VKA patients and clinician knowledge.  Their review of the 
literature indicates that “a change in vitamin K intake was the largest interacting factor for 
accounting for sub-therapeutic INR levels.”  The primary goal of their survey was to examine 
clinician practices for determining diet history and the characteristics of dietary education 
materials that they provided to their patients.  They found that all participants reported providing 
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education to their patients to maintain consistent vitamin K levels.  Some participants reported 
that they advised their patients to avoid foods high in vitamin K and the main factors affecting 
this decision were a low literacy in their patient or a high risk for a thromboembolism.  The 
information provided to patients was typically printed information, with 91% of the material 
being supplied by the manufacturer.  The reading level of this material is not reported.  Their 
overall conclusion is that all clinicians placed an emphasis on diet and obtaining a diet history 
from new VKA patients, however there needs to be improvements in maintaining the emphasis 
on diet in subsequent visits.   
In the published guidelines for the use of anticoagulants (Ansell, Buttaro, Thomas, 
Knowlton, 1997) a high value is placed on the importance of providing dietary education to all 
patients on VKA’s.  Even though some studies have shown an improved patient adherence with a 
pharmacist led education plan (Moreland et al., 2013), nurses continue to provide patient 
education more often and in a more informal setting because they have the greatest access to the 
patient and the patient’s family (Marcum, Ridenour, Shaff, Hammons, & Taylor, 2002).  The 
question becomes, what information is available to nurses to increase their knowledge regarding 
the vitamin K content of foods and how best to provide this information to their patients in a 
format that will be effective?  Dennis et al., (2008) included in their study an assessment of the 
vitamin K knowledge of the clinicians.  They were asked to classify 20 vegetables by vitamin K 
content and had a mean of “64.6 + 10.9 correct out of 100”, so this evidence supports the lack of 
dietary knowledge amongst health care providers.   
Method for Identifying the Literature 
 Four literature searches were done using CINAHL to identify articles written for a 
general nursing audience that provided education on warfarin and vitamin K foods.  The 
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following limitations were established aprior: publication date 2003-2014, English language, 
Human, Geographic subset: USA, and Age group: All Adult.  Boolean phrase searches were 
conducted using the words “patient education and warfarin”, “patient education and warfarin and 
diet” ,“warfarin and vitamin K and patient education” and  “nursing role and patient education 
and warfarin.”  These searches yielded only seven articles in nursing journals.  
 Four articles were essentially based on the results of a telephone survey of patients post-
discharge to assess their knowledge of warfarin (Cheah and Martens 2003; Hu Chow, Dao, Errett 
and Keith, 2006; Cook-Campbell and Sefton, 2010; Polek and Hardie, 2012).  These surveys 
either had very basic information regarding vitamin K content of foods or none at all.   
McCarron (2010) provided a strong background to nurses in clot formation, coagulation 
factors and pathways, parenteral anticoagulants, oral anticoagulants and teaching tips.  It in this 
last section that she provides some specific information about vitamin K rich foods, listing the 
following: broccoli, spinach, collard greens, cabbage, chard, parsley, mayonnaise, canola oil, and 
soybean oil.  She also mentions the necessity of informing patients that they do not need to 
eliminate these foods from their diet only that they are consistent in what they eat. 
Eisenstein (2012) provided a general education article and with continuing education 
credits to its readers.  It contained very little information that is specific to warfarin and patient 
education by two sentences at the bottom of one page regarding vitamin K. “You should avoid 
eating large amounts of vitamin K-rich foods at a single meal.  These include green, leafy, 
vegetables, such as kale, collard greens, spinach and turnip greens.”  Michaels and Regan (2013) 
focus on patient education regarding self-testing and management, making no specific mention 
of vitamin K or vitamin K-rich foods, only that patients need information about nutrition and 
foods that can affect warfarin’s action.   
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 Out of a total of seven articles found specifically in nursing journals that span a period of 
ten years, only three provide specific food items that patients need to know are high in vitamin 
K.  This clearly seems to indicate that assumptions are made regarding a nurse’s knowledge base 
regarding vitamin K-rich foods.  These assumptions can have profound impacts on how 
effectively education is provided and patients are able to maintain a therapeutic INR.  Cook-
Campbell and Sefton (2010) recommend based on their results that “patients need education 
about vitamin K foods and the association with clot formation….and nurses provide more patient 
education during the first 24 months of therapy and have an opportunity to improve patient 
education of warfarin during this time.” 
Patient Education 
In their consensus guidelines for anticoagulation management Ansell, et al. (1997) found 
that patient education initiatives that promoted self-care were the most successful in maintaining 
therapeutic INR levels.  Their guidelines also include a list of what information the patient 
should be able to state, which includes the ability to “identify diet, drug, and alcohol use that 
might cause problems with therapy” without going into specific information on what aspect of 
diet can impact warfarin effectiveness.  In their review of inpatient anticoagulation therapy, 
Nutescu et al., (2013) have stated that “to achieve better patient outcomes, patient education is a 
vital component of an anticoagulation therapy program.”  Diamantouros, Bartle, and Geerts 
(2013) have shown that a majority of the information that patients do receive contains about 63% 
of the content that experts consider to be necessary to maintain patient safety, with the only 
dietary reference being made to alcohol consumption.   
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While there are many aspects regarding patient safety when it comes to taking warfarin, 
there seems to be very little information in the literature regarding vitamin K and foods high in 
vitamin K, other than the general statement of “dark leafy greens” or “green leafy vegetables.”   
Knowledge about vitamin K and its effects on anticoagulation does not carry the urgency that 
patient knowledge of the symptoms of life-threatening events such as stroke or pulmonary 
embolism.  However, it is an element of patient education that could improve adherence and 
therapeutic INR values because of the potential for increased knowledge of the clotting process.  
Wittkwosky and Devine (2004) have shown that for 5% of the patients that are over or under 
anticoagulated, it is due to changes in dietary Vitamin K.  Therefore it seems necessary to 
provide patients with specific information on the vitamin K content of foods and their need to 
maintain consistency in their daily intake.   
What is surprising to find is that there is still no “gold standard” for educational material 
that is provided to patients on warfarin.  In the candidate handbook for Certified Anticoagulation 
Care Providers there is no mention of any patient education regarding Vitamin K content of 
foods (NCBAP, 2013).  Cook-Campbell and Sefton (2010) have also noted that patient education 
on the Vitamin K content of foods and their interaction with warfarin is significantly lacking.   
General improvement of patient education needs multiple approaches as suggested by 
Nutescu et al., (2013) and Cené and DeWalt (2013) and Wilson, Mood, Risk, & Kershaw (2003).  
Their recommendations include professionally trained educators leading a face-to-face 
interaction with the patient, groups training sessions for several patients at once, the use of 
written and/or audiovisual materials, and use of knowledge assessment tools to verify 
understanding of the material.  Nurses are ideal candidates for this role because they have the 
most interaction with patients on a daily basis and are often able to use “teachable moments” to 
WARFARIN AND DIETARY VITAMIN K                                                                               10 
reinforce patient education.  In a study of patient preferences for communicating the benefits of 
medicine, Goodyear-Smith, Kenealy, Wells, Arroll, & Horsburgh (2011) found that over half of 
their study sample preferred pictorial presentations to numbers.  They also showed that clinicians 
need to use multiple methods to communicate risks to patients. 
One significant barrier to patient education is the contrast between the literacy level of 
the patient and the material that they are provided (Cené and DeWalt, 2013; Eisenstein, 2012; 
Ryan et al., 2008).  One way to address literacy levels would be to provide simple cue cards 
(Cook-Campbell and Sefton, 2010).   In addressing dietary issues for any type of patient, keeping 
a daily journal has often been the recommendation.  However regarding vitamin K content, 
Couris, Tataron, Booth, Dallal, Blumberg, & Dwyer, (2000) found that having patients maintain 
a complete diet record to be cumbersome and time consuming not only for the patient but for the 
health care provider to code and subsequently analyze record entries.  They developed a “K-
card” for patients to use to determine their weekly vitamin K intake however; it was not tested on 
actual patients.  
Dennis et al. (2008) classified vegetables into three basic categories, low (<10mcg), 
medium (10-99mcg) and high (>100mcg) when they assessed care-giver and patient knowledge 
about the vitamin K content of certain foods.  The category most often missed was “medium” 
level food items.  Rather than have patients try to determine what their average daily intake is, it 
may be more effective to have them determine what ranking they are: low, medium, or high so 
they are better able to maintain their diet consistency and maintain a therapeutic INR level.  In 
developing this ranking level, Dennis et al, (2008) stressed the importance of focusing not only 
on serving size, but more on the actual amount of food item typically eaten. 
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Development of the Patient Dietary Tool 
I developed a patient tool (see Appendices A, B, and C) that combines a ranking system 
for vitamin K content of foods into low, medium, high, and extremely high.  These levels were 
chosen based on the current USDA recommended daily allowance of 90micrograms (mcg) of 
vitamin K for women and 120mcg for men (Vitamin K Foods, 2014).  Patients on warfarin 
should not be discouraged from consuming certain healthy vegetables.  The latest USDA (2011) 
dietary guidelines from their Choosemyplate website suggest not only increasing our daily 
servings of vegetables but to “choose vegetables rich in color and to brighten our plate with 
vegetables that are red, orange, or dark green” (USDA, 2011). Vitamin K has also been linked to 
reducing atherosclerosis and boosting bone health (Barclay, 2007).  This tool will enable patients 
to incorporate these vegetables into their diet on a consistent basis, which is the key to 
maintaining therapeutic INR levels. 
The patient tool has been designed to be simple to read so rather than list vitamin K 
content of each food item; four different levels of vitamin K content have been used.  These 
levels are low (<10mcg), moderate (10-50mcg), high (51-100mcg), and extremely high 
(>100mcg).  These categories were chosen based on varying assumptions of the average person’s 
diet and the recommended daily allowance of vitamin K.  For example, if a patient consumed 
daily, on average, three items from the low category, s/he would still be consuming less than the 
recommended daily allowance.  Serving sizes were standardized into 1cup amounts consistent 
with the USDA recommended servings.  Food categories were also grouped to keep the list short 
and confined to a single sheet for simplicity.  The tool is also designed to reduce patient dietary 
restrictions, giving them more options in their daily diet.  By having more options, patients 
should feel more in control of their daily activities and more likely to adhere to the diet. 
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In order to begin to demonstrate cultural competence and cultural awareness, certain food 
items were included to account for varying cultures in the U.S. and also for age, since a majority 
of warfarin users are over 65 (Cook-Campbell & Sefton, 2010.)  According to Campinha-Bacote, 
(2003) it is the long-standing disparities in the health status of people from culturally diverse 
backgrounds that has challenged health care providers and they must begin to address these 
differences and make them a priority.  Since the demographics of the U.S. are changing, it is 
important to acknowledge these cultural changes in the dietary preferences of warfarin patients.  
In addition to an English Version (Appendix A), the tool was translated into Spanish (Appendix 
B) and Mandarin Chinese (Appendix C) to aid these patients in their INR maintenance and to 
begin to increase the cultural knowledge of nurses that will be using this tool. 
Options for Administering Patient Tool 
 It is recommended to have a multidisciplinary approach to patient education regarding 
warfarin and adherence to INR levels.  Anticoagulation treatment is typically initiated with 
inpatients (Dennis et al., 2008) and most hospitals now use pharmacists when providing 
education to first time patients (Nutescu  et al., 2013, Zeolla et al., 2006).  However, Marcum et 
al., (2002) and Cook-Campbell & Sefton, (2010) have shown that a majority of informal patient 
education is done by registered nurses.  Dennis et al. (2008) found that vitamin K content of food 
item knowledge among health care providers was minimal.  Therefore, it is important for nurses 
to be educated on the vitamin K content of foods since they are most likely the ones to witness 
what food items the patients will eat at the bedside.  This also presents them with the opportunity 
to reinforce accurate information and use of the tool.  This tool can also improve their knowledge 
and scope of practice since nurses are the ones to review medication information with patients 
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upon discharge and answer patients’ questions.  This also improves their ability to evaluate the 
patient’s understanding of the use of the tool prior to discharge and maintain the nursing process. 
One way to achieve this would be an in-service on how to use the tool. The nurses should 
complete the tool themselves, as if they were the patient to gain a full understanding on how to 
use it.  The improvement in a nurses’ knowledge of vitamin K content of foods can only enhance 
bedside care because of the frequency of informal educational opportunities and teachable 
moments.  As Habel (2005) and Wingard (2005) have suggested, it is nurses who spend more 
time with patients than any other team member and are instinctively assessing the patient, which 
provides them with the opportunity to develop a trusting relationship, determine learning needs 
and abilities, and provide continuity.  It becomes clear that nurses are at the forefront of 
improving patient understanding of dietary consistency, as long as they have the knowledge 
themselves. This impact of nursing care and education is supported in a study by González, B., 
Lupón, J., Herreros, J., Urrutia, A., Altimir, S., Coll, R., Valle, V. (2005). They demonstrated 
that nurse-guided education changed the self-care behavior of patients with heart failure in 
several important aspects, such as weight and blood controls, and increased patient knowledge 
and understanding of the disease and treatment.   
Once the in-service has been completed, a nurse will present the tool to a patient prior to 
discharge but after s/he has been provided general warfarin education by a pharmacist.  The 
patient is requested to look over the lists of food items and highlight what s/he eats, on average, 
over a week.  This will then determine which overall category the patient falls into, being low, 
moderate, high, or extremely high.  If the patient falls into the low category, it could be 
suggested that they alter their diet to meet the minimum daily requirements.  Enabling a patient 
to be more actively involved in their health care decisions can only result in healthier behavior, 
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greater improvement in their adherence to their INR levels, and will be better at self-monitoring 
their diet (Sisneros, 2013).  It is the goal of modern patient education for nurses to empower their 
patients to be able to make appropriate decisions regarding their health care and become more 
autonomous in the daily maintenance of their illness (Wingard, 2005). 
If additional questions still arise after this exercise, then a hospital registered 
nutritionist/dietician could be included on a consult.  This patient tool can also be used in the 
outpatient setting with home health care nurses or rehabilitation nurses due to their potential 
impact on patient care and education as shown by Cook-Campbell & Sefton (2010) and Polek & 
Hardie (2012).   
Conclusion 
Warfarin is an anticoagulant that will probably be continued to be prescribed even though 
there are several new anticoagulants available.  It is disappointing to discover that after more 
than fifty years, there is still no gold standard when it comes to patient education on warfarin.  
The tool developed during this review has the potential to increase patient understanding of the 
importance of consistency in dietary vitamin K which can only improve patient adherence to a 
therapeutic range for their INR values.  This tool will function to expand a patient’s dietary 
choices and dispel prior inaccurate education that limited their intake of vitamin K rich foods.  It 
emphasizes the importance of consistency by placing the patient in a category of low, medium, 
high, or extremely high which should likely lead to a stabilizing of INR values.  This tool 
removes dietary control as one of the many variables that contributes to INR levels and addresses 
some of the lack of patient education in the past. 
One key to the proper use of this tool is an in-service training for nurses to understand the 
tool and an inclusion of a full health care team, including the primary care physician, pharmacist, 
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nutritionist/dietician, and the HCP supervising the patient post discharge.  Nurses are the most 
trusted profession and are essential to opening and maintaining the channels of communication 
between the patient and the health care team.  This creates a partnership between the patient and 
the nurse, allowing the nurse to act as a facilitator in aiding the patient’s ability to have more 
control over their healthcare and creating a sense of shared governance between the nurse and 
the health care team. 
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Appendix A-English 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: Serving Sizes are essentially 1 cup of each item unless otherwise indicated. 
Vitamin K sources are PTINR.com and inrtracker.com 
Recommended daily allowance of Vitamin K for women is 90mcg and men is 120mcg 
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Appendix B-Spanish 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTA: tamaño de las porciones son esencialmenta 1 taza de cada artículo, a menos que se 
indique lo contrario. 
Fuentes de vitamina K es PTINR.com y inrtracker.com 
Cantidad diaria recommendada de vitamina K para las mujeres es 90mcg y los hombres es 
120mcg 
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Appedix C-Mandarin Chinese 
 
 
 
 
注意：每份为1勺，除非有特殊注明 
 
Sources are PTINR.com and inrtracker.com 
 
女性每日的摄入钾量：90MCG；男性：120MCG 
